AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Ratios and Metrics

Market cap in millions NZD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	395	282	328	363	378	518
Market Cap Growth	30.00%	-14.06%	-9.54%	-4.00%	-26.99%	46.56%
Enterprise Value	420	305	363	395	414	556
Last Close Price	3.77	2.67	3.09	3.41	3.56	4.88
PE Ratio	23.30	23.58	21.03	34.06	19.04	68.17
Forward PE	25.23	16.79	19.41	19.12	18.43	30.80
PS Ratio	1.67	1.36	1.68	2.32	2.90	4.58
PB Ratio	4.03	2.91	3.74	4.95	6.07	14.15
P/TBV Ratio	10.20	3.36	4.47	6.35	8.16	24.65
P/FCF Ratio	43.43	21.88	11.42	31.74	27.34	787.96
P/OCF Ratio	42.51	21.41	11.37	31.20	26.71	690.25
PEG Ratio	0.70	0.82	0.54	1.61	0.38	-
EV/Sales Ratio	1.78	1.47	1.86	2.52	3.18	4.92
EV/EBITDA Ratio	16.11	16.92	14.74	19.89	20.04	50.70
EV/EBIT Ratio	17.36	17.27	14.98	20.10	20.31	51.93
EV/FCF Ratio	46.13	23.64	12.63	34.58	29.96	846.29
Debt / Equity Ratio	0.39	0.31	0.37	0.52	0.65	1.15
Debt / EBITDA Ratio	1.45	1.59	1.27	1.85	1.90	3.61
Debt / FCF Ratio	4.16	2.33	1.12	3.33	2.93	64.26
Asset Turnover	1.48	1.24	1.25	1.14	1.12	1.18
Inventory Turnover	2.48	2.38	2.34	2.21	2.04	2.28
Quick Ratio	0.69	1.25	1.15	1.12	1.30	1.01
Current Ratio	1.51	2.51	2.30	2.38	2.67	2.12
Return on Equity (ROE)	18.27%	12.33%	19.38%	15.72%	40.14%	28.91%
Return on Assets (ROA)	9.46%	6.58%	9.67%	8.93%	10.96%	6.97%
Return on Invested Capital (ROIC)	13.90%	11.21%	16.02%	13.17%	23.92%	15.78%
Return on Capital Employed (ROCE)	24.00%	13.90%	20.30%	18.20%	20.70%	14.70%
Earnings Yield	4.41%	4.24%	4.75%	2.94%	5.25%	1.50%
FCF Yield	2.30%	4.57%	8.76%	3.15%	3.66%	0.13%
Dividend Yield	0.48%	0.67%	0.52%	0.32%	-	-
Payout Ratio	10.82%	14.03%	7.39%	-	-	2.42%
Buyback Yield / Dilution	7.83%	-	-0.02%	-0.16%	-1.34%	-6.15%
Total Shareholder Return	8.30%	0.67%	0.50%	0.16%	-1.34%	-6.15%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.